Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/000220 stock hub

KRX/000220 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KRX/000220is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
65.2B
Korea Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
KRX/000220
In the news

Latest news · KRX/000220

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 9.8P50 17.1P75 31.9
Trailing P/E8.6
P25 12P50 23.1P75 39.5
ROE6.6
P25 -17.1P50 0.7P75 8.5
ROIC7.7
P25 -9P50 1.3P75 6.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KRX/000220 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
229
Groups with data
11
Currency
KRW
Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
South Korea
Country code
KR
Employees
254
Enterprise value
KRW 73.9B
Exchange
Korea Stock Exchange
Financial currency
KRW
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
KR7000220004
Last refreshed
2026-05-10
Market cap
KRW 65.2B
Price
KRW 4,140
Price currency
KRW
Rev Per Employee
554,664,043.15x
Sector
Healthcare
Sic
2834
Symbol
krx/000220
Website
https://www.yuyu.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
12.51%
EV Earnings
9.07x
EV/EBIT
6.38x
EV/EBITDA
4.3x
EV/FCF
9.69x
EV/Sales
0.52x
FCF yield
11.7%
P/B ratio
0.46x
P/E ratio
8.61x
P/S ratio
0.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
7.82%
EBITDA Margin
11.8%
FCF margin
5.41%
Gross margin
38.04%
Gross Profit
KRW 53.6B
Gross Profit Growth
4.31%
Gross Profit Growth Q
2.23%
Gross Profit Growth3 Y
0.39%
Gross Profit Growth5 Y
3.48%
Net Income
KRW 8.2B
Net Income Growth
-6.49%
Net Income Growth Quarters
2%
Net Income Growth Years
0%
Net Income Growth5 Y
52.19%
Pretax Margin
6.73%
Profit Margin
5.79%
Profit Per Employee
KRW 32.1M
Profitable Years
2
ROA
3.32
Roa5y
1.44
ROCE
7.43
ROE
6.62
Roe5y
1.17
ROIC
7.7
Roic5y
3.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

24
MetricValue
Cagr10y
-3.29%
Cagr15y
3.05%
Cagr1y
-7.89%
Cagr20y
-0.82%
Cagr3y
-10.35%
Cagr5y
-14.99%
Div CAGR10
2.48%
Div CAGR3
3.08%
Div CAGR5
1.84%
EPS Growth
-6.24
EPS Growth Quarters
1
EPS Growth Years
2
EPS Growth5 Y
42.11
FCF Growth
-57.26%
FCF Growth Q
215.98%
OCF Growth
-36.36%
OCF Growth Q
126.45%
OCF Growth10 Y
27.83%
Revenue Growth
5.81x
Revenue Growth Q
4.17x
Revenue Growth Quarters
3x
Revenue Growth Years
1x
Revenue Growth3 Y
0.48x
Revenue Growth5 Y
7.5x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
KRW 0.68
Assets
KRW 207.2B
Cash
KRW 32.7B
Current Assets
KRW 96.9B
Current Liabilities
KRW 58.9B
Debt
KRW 27.9B
Debt EBITDA
KRW 1.68
Debt Equity
KRW 0.2
Debt FCF
KRW 3.66
Equity
KRW 140.5B
Interest Coverage
4.44
Liabilities
KRW 66.7B
Long Term Assets
KRW 110.3B
Long Term Liabilities
KRW 7.7B
Net Cash
KRW 4.8B
Net Cash By Market Cap
KRW 7.34
Net Cash Growth
-46.89%
Net Debt EBITDA
KRW -0.29
Net Debt Equity
KRW -0.03
Net Debt FCF
KRW -0.63
Tangible Book Value
KRW 124.2B
Tangible Book Value Per Share
KRW 7,689
WACC
7.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.64
Inventory Turnover
2.16
Net Working Capital
KRW 32.9B
Quick ratio
0.89
Working Capital
KRW 38B
Working Capital Turnover
KRW 3.74

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
0.27%
Dividend Growth
15%
Dividend Growth Years
1%
Dividend per share
KRW 100
Dividend Years
2
Dividend Yield
2.42%
Ex Div Date
2025-12-29
Last Dividend
KRW 115
Payout Ratio
23.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-28.4%
1Y total return
-7.89%
200-day SMA
4,345.7
3Y total return
-27.96%
50-day SMA
4,274.1
50-day SMA vs 200-day SMA
50under200
5Y total return
-55.6%
All Time High
18,950
All Time High Change
-78.15%
All Time High Date
2021-04-16
All Time Low
398.9
All Time Low Change
937.74%
All Time Low Date
1992-01-20
ATR
92.87
Beta
0.38
Beta1y
0.44
Beta2y
0.22
Ch YTD
-8.31
High
4,160
High52
5,100
High52 Date
2025-12-17
High52ch
-18.82%
Low
4,070
Low52
4,000
Low52 Date
2025-11-05
Low52ch
3.5%
Ma50ch
-3.14%
Price vs 200-day SMA
-4.73%
RSI
41.22
RSI Monthly
41.43
RSI Weekly
41.71
Sharpe ratio
-0.47x
Sortino ratio
-0.42
Total Return
2.69%
Tr YTD
-8.31
Tr15y
56.81%
Tr1m
1.35%
Tr1w
-2.47%
Tr3m
-3.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

4
MetricValue
Operating Income
KRW 11B
Operating Income Growth
-12.42
Operating Income Growth5 Y
11.93
Operating margin
7.82

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
10,086,524%
Net Borrowing
-11,966,117,860
Shares Insiders
35.95%
Shares Institutions
0.04%
Shares Out
15,747,462
Shares Qo Q
-24.85%
Shares Yo Y
-0.27%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

64
MetricValue
Adjusted FCF
KRW 7.6B
Average Volume
49,521.55x
Bv Per Share
7,864.4
CAPEX
KRW -8.3B
Ch10y
-39.34
Ch15y
20.17
Ch1m
1.35
Ch1w
-2.47
Ch1y
-9.9
Ch20y
-40
Ch3m
-3.72
Ch3y
-31.11
Ch5y
-58.81
Change
1.22%
Change From Open
1.22
Close
4,090
Days Gap
0
Depreciation Amortization
5,607,601,000
Dollar Volume
174,397,500
Earnings Date
2026-04-03
EBIT
KRW 11B
EBITDA
KRW 16.6B
EPS
KRW 481
F Score
6
FCF
KRW 7.6B
FCF EV Yield
10.31x
FCF Per Share
KRW 484
Financing CF
-16,476,614,560
Fiscal Year End
December
Founded
1,941
Goodwill
153,766,000
Graham Number
9225.6411
Graham Upside
122.8
Income Tax
KRW 366M
Investing CF
-12,376,371,730
Is Primary Listing
1
Last Earnings Date
2026-02-20
Last Report Date
2025-12-31
Last Split Date
2021-03-30
Last Split Type
Forward
Lynch Fair Value
KRW 12,025
Lynch Upside
190.5
Ma150
4,318.9
Ma150ch
-4.14%
Ma20
4,251.8
Ma20ch
-2.63%
Net CF
-12,741,636,680
Open
4,090
P FCF Ratio
8.55
P OCF Ratio
4.11
Payment Date
2026-04-15
Position In Range
77.78
Ppne
93,456,715,500
Price Date
2026-05-08
Price EBITDA
KRW 3.92
Ptbv Ratio
0.52
Relative Volume
0.85x
Revenue
140,884,666,960x
Tax By Revenue
0.26x
Tax Rate
3.86%
Tr20y
-15.22%
Tr6m
2.24%
Volume
42,125
Z Score
1.94
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

KRX/000220 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+2.4%
$100 annual per share
Payout ratio
+23.9%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+1.8%
1 consecutive years of growth
Total shareholder yield
+2.7%
Next ex-dividend date: 2025-12-29
Performance

KRX/000220 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-7.9%
S&P 500 1Y: n/a
3Y total return
-28.0%
S&P 500 3Y: n/a
5Y total return
-55.6%
S&P 500 5Y: n/a
10Y total return
-28.4%
S&P 500 10Y: n/a
Ownership

Who owns KRX/000220?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.0%
Share of float held by funds and institutions
Insider ownership
+35.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.3%
Negative means the company is buying back shares.
Technical

KRX/000220 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
41.2
Neutral momentum band
Price vs 200-day MA
-4.7%
50/200-day relationship not available
Beta (5Y)
0.38
Less volatile than the market
Sharpe ratio
-0.47
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KRX/000220

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/000220 stock rating?

krx/000220 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/000220 analysis?

The full report lives at /stocks/krx/000220/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/000220?

The latest report frames krx/000220 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/000220 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.